Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Conestoga Capital Advisors LLC

Conestoga Capital Advisors LLC trimmed its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 18.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 96,453 shares of the biotechnology company's stock after selling 22,265 shares during the quarter. Conestoga Capital Advisors LLC owned about 0.13% of Axon Enterprise worth $38,543,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Motley Fool Asset Management LLC boosted its stake in Axon Enterprise by 238.7% in the first quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company's stock worth $153,981,000 after buying an additional 346,838 shares in the last quarter. 1832 Asset Management L.P. bought a new position in shares of Axon Enterprise during the first quarter valued at approximately $81,630,000. International Assets Investment Management LLC bought a new stake in Axon Enterprise in the third quarter valued at $871,860,000. Vanguard Group Inc. boosted its stake in shares of Axon Enterprise by 2.7% during the 1st quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company's stock valued at $2,547,878,000 after purchasing an additional 212,401 shares in the last quarter. Finally, Swedbank AB bought a new position in shares of Axon Enterprise in the 1st quarter worth approximately $39,923,000. Hedge funds and other institutional investors own 79.08% of the company's stock.

Axon Enterprise Trading Up 0.6 %

Shares of NASDAQ:AXON traded up $2.34 during trading on Friday, reaching $425.84. 600,522 shares of the company were exchanged, compared to its average volume of 519,765. The business's fifty day simple moving average is $400.22 and its 200-day simple moving average is $339.14. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52. Axon Enterprise, Inc. has a 12-month low of $209.02 and a 12-month high of $455.17. The firm has a market capitalization of $32.18 billion, a PE ratio of 112.93, a P/E/G ratio of 11.18 and a beta of 0.94.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.02 by $0.18. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The business had revenue of $504.00 million for the quarter, compared to the consensus estimate of $478.35 million. During the same quarter in the prior year, the company earned $0.80 EPS. The business's revenue was up 34.5% compared to the same quarter last year. On average, research analysts anticipate that Axon Enterprise, Inc. will post 1.79 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the stock. Barclays upped their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an "overweight" rating in a report on Wednesday, August 7th. Needham & Company LLC raised their price target on shares of Axon Enterprise from $400.00 to $525.00 and gave the company a "buy" rating in a research report on Tuesday, October 22nd. Northland Securities increased their price objective on Axon Enterprise from $330.00 to $365.00 and gave the company an "outperform" rating in a research report on Thursday, August 8th. Jefferies Financial Group initiated coverage on shares of Axon Enterprise in a research note on Wednesday, July 17th. They set a "buy" rating and a $385.00 target price on the stock. Finally, Craig Hallum raised their target price on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a "buy" rating in a report on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $388.23.

Insider Buying and Selling

In other news, Director Jeri Williams sold 110 shares of the stock in a transaction on Monday, September 30th. The stock was sold at an average price of $400.00, for a total transaction of $44,000.00. Following the completion of the sale, the director now owns 1,934 shares in the company, valued at approximately $773,600. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, Director Jeri Williams sold 110 shares of the business's stock in a transaction on Monday, September 30th. The shares were sold at an average price of $400.00, for a total transaction of $44,000.00. Following the sale, the director now directly owns 1,934 shares of the company's stock, valued at $773,600. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Patrick W. Smith sold 80,300 shares of Axon Enterprise stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $371.78, for a total value of $29,853,934.00. Following the sale, the chief executive officer now directly owns 3,015,366 shares of the company's stock, valued at approximately $1,121,052,771.48. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 371,172 shares of company stock worth $137,000,162 in the last three months. 6.10% of the stock is owned by insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.